Abstract
Background
The involvement of CD8+T cells in schistosomiasis is being increasingly appreciated, but the underlying mechanism is not well defined.
Results
In this study, we showed that the absence of Batf3 alleviated liver damage in Batf3 −/− mice infected with S. japonicum. We found alleviated liver granulomatous inflammation in Batf3 −/− mice with schistosomiasis japonica could not be attributed to the difference in schistosome egg or worm burden. The stronger Tc1 cell responses observed in Batf3 −/− mice suggested that the deletion of Batf3 resulted in more activation of CD8+T cells unexpectedly during the natural infection of schistosomes. We detected a small amount of CD8α+ DCs in the spleen of Batf3 −/− mice at 9w post-infection. This small amount of newly generated CD8α+ DCs might contribute to enhanced activation of CD8+T cells via cross-presentation and activation which then attenuate hepatic pathological damage found in Batf3 −/− mice.
Conclusions
Our study provides evidence that Batf3 is associated with the immunoregulation of the liver granuloma formation, which may confer a new options for schistosomiasis treatment.
Keywords: Schistosoma japonicum, Dendritic cells, CD8α+, CD8+T cells, Batf3, Helminth
Background
A challenging problem in the prevention and treatment of schistosomiasis is re-infection and immunopathological damage of the liver in patients who live in endemic areas [1, 2].The secretion of soluble egg antigen (SEA) in the late stage of schistosomiasis causes Th2-dominant immune response to form granulomas [3, 4]. Repeated infection will eventually lead to secondary liver fibrosis and advanced schistosomiasis, and patients may have upper gastrointestinal bleeding, hepatic coma and other serious complications, and even death [2].
Current studies on the immune mechanism of schistosomiasis infection have focused on CD4+T cells and antibody response. CD8+T cells play an important role in host defense against bacterial, viral, protozoa infection and anti-tumor processes, however, the role of CD8+T cells in parasitic helminth infection, such as schistosomiasis, remains unclear. CD8+T cells recognize the antigenic peptide presented by the MHCI molecule and kill the target cells, or induce apoptosis of the target cells by direct contact (secretion of perforin, granzyme, lymphotoxin, or by Fas / FasL pathway). Schistosomes can adsorb host MHCI, suggesting that host CTL may play a role in the immune response to multicellular worms [5]. Chensue et al. [6] proposed that modulated granulomatous inflammatory response was maintained by effector and regulator lymphocytes in mice with chronic infection of Schistosoma mansoni. Among those studied, Ly-2+ (CD8+) T lymphocytes were primarily responsible for suppressing granuloma formation. Another study [7] found that during the chronic infection stage of S. mansoni, CD8+ T cell activity increased, which can significantly reduce the growth of egg granuloma, and the subsequent formation of new granulomas was significantly slower at 16–20 weeks post-infection. When lymph nodes and spleen cells in chronic stage of infection were transferred to acutely infected mice, they can significantly reduce granuloma formation in the recipients. However, when the CD8+ T cells were removed from these cells, the inhibition effect on granuloma disappeared [8]. Pancré et al. [9, 10] reported that single immunization of S. mansoni recombinant glutathione S-transferase (rSm28GST) induced the immunity to the infection of schistosomiasis and increased spleen CD8+T cell activity, resulting in antigen-specific CTL response. Sm28GST-specific CD8+T cells were further passively transferred to naive mice, after the infection of schistosomiasis, the number of liver granuloma reduced, and liver fibrosis alleviated in the mice. However, after treatment with anti-CD8 antibody, the protective effect mediated by Sm28GST was significantly reducedx. Consistent with the above studies, our previous study in TLR2 −/−, TLR4 −/− mice and pigs suggest that CTL responses are involved in the immune mechanism of resistance to S. japonicum infection [11, 12].
Moreover, CD8+T cells secrete inflammatory factor IFN-γ to regulate immune response and reduce pathological damage during the infection of S. mansoni. CD8+T cells in the spleen of mice infected with S. mansoni responded to schistosome antigen presented by APC and produced IFN-γ [13]. After S. mansoni infection, 4 weeks of IFN-γ intramuscular injection reduced collagen deposition in mouse liver significantly [14]. In the spleen of mice infected with S. mansoni, the number of CD8+T cells decreased, type 2 immune environment established and further led to the apoptosis of Tc1(CD3+CD8+IFN-γ+) cell. Thus, schistosomes may inhibit type 1 immune response by reducing Tc1 cells to facilitate the deposition of eggs and cause pathological damage [15].
Taken together, CD8+T cells may play an immunological role in anti-schistosomiasis infection. However, the mechanism by which CD8+T cell response is generated in schistosome infection remains unclear. In this study, we found the absence of Batf3 alleviated liver damage in Batf3 −/− mice infected with S. japonicum and that the alleviated liver granulomatous inflammation could not be attributed to the difference in schistosome egg or worm burden. The stronger Tc1 cell responses observed in Batf3 −/− mice suggested that the deletion of Batf3 activated CD8+T cells unexpectedly during the natural infection of schistosomes. Then we detected a small amount of CD8α+ DCs in the spleen of Batf3 −/− mice at 9w post-infection. This small amount of newly generated CD8α+ DCs may have a more powerful function in cross-presenting and activate CD8+T to secret IFN-γ+ which can attenuate hepatic pathological damage in Batf3 −/− mice.
Methods
Mice
B6.129S(C)-Batf3 tm1Kmm/J mice (Stock No: 013755/Batf3 −/−) were purchased from Jackson Labs [16]. Wild-type C57BL/6 J (B6) mice were purchased from the Model Animal Research Center, Nanjing University (Nanjing, China). 6–8 weeks old female mice were used in all experiments. All mice were maintained according the institutional guidelines at Nanjing Medical University.
Parasites and infections
Schistosoma japonicum cercariae were maintained in Oncomelania hupensis snails (laboratory-infected with a Chinese mainland strain), which were purchased from the Jiangsu Institute of Parasitic Disease (Wuxi, China). Snails were placed in deionized water and exposed to incandescent light for 3–4 h for cercarial release. For infection, the cercariae were counted and placed on glass cover slips by a 10 μl bacteriological loop. Batf3 −/− and B6 mice were infected with 10 ± 2 S. japonicum cercariae through their shaved abdomens.
Parasitological assessments
For parasite burden determination (adult worm recovery, egg burdens and area of single egg granuloma in the livers), all mice were sacrificed 9 weeks post-infection. The worms were collected and counted through perfusion of the portal vein with PBS. After perfusion, the intestinal tract of each mouse was examined for residual worms. The liver samples, except left front lobes, of each mouse were weighted and digested in 5% KOH for 18 h at 37 °C. Each liver sample was counted 3 times for released eggs under the microscope and the mean count was used as eggs per gram (EPG) in mice. Left front lobes of livers from each mouse were fixed in 4% paraformaldehyde, embedded in paraffin and stained with haematoxilin and eosin according to standard protocols. Single-egg granulomas were examined and their sizes were calculated using AxioVision Rel 4.7 (Carl Zeiss GmbH, Jena, Germany). At least 10 single egg granulomas per liver section were photographed. Sirius red stainings were observed to investigate the deposition of collagen fibers in liver of Batf3 −/− and B6 mice at 9 weeks post-infection and the results were analyzed using imageJ software (National Institutes of Health, America).
Flow cytometry detection
Percentages of Th1 (CD3+CD4+IFN-γ+), Th2 (CD3+CD4+IL-4+), Tc1 (CD3+CD8+IFN-γ+), Tc2 (CD3+CD8+IL-4+) cells in the spleens of Batf3 −/− and B6 mice at 0, 3, 6 and 9 weeks post-infection was detected by flow cytometry. Splenocytes were prepared by gently forcing spleen tissue through a nylon net into incomplete RPMI-1640 medium (Gibco-Invitrogen, Grand Island, NY, USA) supplemented with 100 U/ml penicillin and 100 U/ml streptomycin (Gibco-Invitrogen), followed by red blood cell (RBC) lysis to remove erythrocytes. Then 2.0 × 106 splenocytes cells were stimulated with ionomycin (1 μg/ml) and PMA (25 ng/ml) in the presence of 10 μg/ml Brefeldin-A (Enzo Life Science, New York, USA) for 6 h at 37 °C in 5% CO2. After 6 h, the cells were surface stained with APC-anti-CD3e, FITC-anti-CD4 (or CD8). Subsequently, the cells were washed, fixed and permeabilized with Cytofix/Cytoperm buffer and stained with PE conjugated antibodies against IFN-γ or IL-4 (or isotype IgG2a control antibody) (eBioscience, San Diego, CA, USA) following the manufacturer’s instruction. Stained cells were detected by flow cytometry (Becton Dickinson) and the data were analyzed using FlowJo7.6 software.
Real-time polymerase chain reaction
Total RNA was extracted from 1 × 106 splenocytes using TRIzol reagent (Invitrogen, Life Technologies Carlsbad, CA, USA). The cDNA was synthesized with PrimeScript RT reagent kit (Takara, Otsu, Shiga, Japan) according to the manufacturer’s protocol. PCR was performed on the ABI PRISM 7300 (Applied Biosystems, USA) using Power SYBR Green PCR Master Mix (Applied Biosystems, USA). Primers specific for β-actin, Batf3, Irf8 and PU.1 are listed in Table 1. PCR cycling protocol was as follows: 50 °C for 2 min, 95 °C for 10 min, followed by 40 cycles at 95 °C for 15 s, 60 °C for 1 min. The housekeeping gene β-actin was used as an internal control and the data were analyzed with 7300 System SDS Software v1.2.1 (Applied Biosystems, USA). Quantitation of relative mRNA expression was calculated using the 2−ΔΔCt method [17].
Table 1.
sequence (5'→3') | ||
---|---|---|
β-actin | sense | TTCCTTCTTGGGTATGGAAT |
antisense | GAGCAATGATCTTGATCTTC | |
Irf8 | sense | GGGTCAGTACACAACAGGGG |
antisense | CTAGCTGCGTGGAGCATGTA | |
PU.1 | sense | CCTCGATACTCCCATGGTGC |
antisense | GGCTGGGGACAAGGTTTGAT | |
Batf3 | sense | TTTGTGCAGCTTCGGTCAGA |
antisense | CCGGACAAAGGAGGAGTGAG | |
Id2 | sense | CGGGGCTGATCTGGGAAAAT |
antisense | CACAGCGTAACCTCGTCTTC | |
Nfil3 | sense | ATGTTACAGGCGTGCAAAATGG |
antisense | TGATCGCTATGGCTTTCTCCA |
Statistical analysis
Statistical analyses were performed using GraphPad Prism version 5.01 for Windows(USA, GraphPad Software). The data are expressed as mean ± SEM. Student’s t-test and one-way analysis of variance (ANOVA) were performed to test for differences. For all tests, significance was considered for P < 0.05.
Results
The number of CD8α+ DCs changed consistently with the trend of Th1 response during the infection with S. japonicum
We established mouse model of schistosomiasis infection in B6 mice and detected the number of CD8α+DCs in the spleen at 0, 3, 6 and 9 weeks post-infection. We found that the number of CD8α+DCs increased quickly after infection and reached a peak at 3 weeks after infection, beginning to decrease from 6 weeks post-infection to the lowest point at 9 weeks post-infection (F (3,12) = 300.9, P < 0.0001) (Fig. 1). This change was consistent with the trend of Th1 response during S. japonicum infection. In the initial 2–4 weeks after infection, under the stimulation of migrating schistosomula, the host showed Th1 type (IFN-γ, TNF) response. Once egg production begins, Th1 type response declined rapidly, and Th2 type (IL-4, IL-13, IL-10, IL-5) response started [18, 19].
Batf3 null mutation alleviates mouse liver granulomatous inflammation in S. japonicum infection
To evaluate the role of CD8α+ DCs in schistosome infection, we used Batf3 −/− mice which lack splenic CD8α+DCs, because of the deletion of Batf3 (Fig. 1c), to establish a schistosome infection model. We found that the granulomas developed after the deposition of parasite eggs in the livers of both Batf3 −/− and WT control B6 mice. The average size of liver granuloma in Batf3 −/− mice was significantly smaller than that in the B6 mice at 9 weeks post-infection (t (24) = 2.952, P = 0.0121, Fig. 2a, b). The average integrated optical density (AOD) in Batf3 −/− mice was significantly lower than that in the B6 mice at 9 weeks post-infection (t (21) = 2.141, P = 0.0441, Figs. 2a, c) which indicated less deposition of collagen fibers in liver of Batf3 −/−mice. These data suggest that CD8α+ DCs may be involved in the regulation of the granulomatous response to S. japonicum infection.
Similar worm and egg burdens in Batf3−/− and B6 mice infected with S. japonicum
After infection, schistosomula developed into adults and laid eggs; matured schistosome miracidium within eggs can secrete soluble egg antigen (SEA) and cause granulomatous response [20]. To clarify whether the difference of liver granulomatous inflammation between Batf3 −/− and B6 mice was caused by the different worm and egg burdens, we evaluated parasite burdens of both groups at 9 weeks post-infection and the results showed that there were no significant differences in the numbers of paired worms (t (12) = 0.4924, P = 0.6483) (Fig. 2d), adult worms (t (12) = 0.07892, P = 0.9421) (Fig. 2e), total liver eggs (t (12) = 0.8675, P = 0.4109) (Fig. 2f) and EPG in the liver (t (12) = 0.9388, P = 0.3753) (Fig. 2g) between Batf3 −/− and B6 mice. These results indicate that the alleviated liver granulomatous inflammation in Batf3 −/− mice with schistosomiasis japonica is caused by other mechanisms rather than the difference in schistosome egg or worm burden.
Tc1 cell responses are stronger in S. japonicum infected Batf3−/− mice
After infection, migrating schistosomula triggered Th1 polarization, which can downregulate hepatic granuloma formation by secreting INF-γ [21, 22]. Egg production can change the immune response to a bias of Th2 (caused by SEA), which can promote the liver lesion [21, 23]. Thus, we detected Th1 (CD3+CD4+IFN-γ+), Th2 (CD3+CD4+IL-4+), Tc1 (CD3+CD8+IFN-γ+) and Tc2 (CD3+CD8+IL-4+) cell responses in Batf3 −/− and B6 mice by flow cytometry. During the first 3 weeks post-infection the percentage of Th1 cells in the spleen increased quickly in both Batf3 −/− and B6 mice and then decreased from 6 weeks post-infection, but there was no significant difference in Th1 cells responses between these two groups (F (7,15) = 0.01368, P = 0.9080) (Fig. 3a, b). During the first 3 weeks post-infection the percentage of Th2 cells in the spleen increased slowly in both Batf3 −/− and B6 mice, but the proportion of Th2 cells in both Batf3 −/− and B6 mice experienced a faster increase after 3 weeks, although there was still no significant difference between these two groups (F (7,14) = 0.02747, P = 0.8700) (Fig. 3c, d). In addition, the percentage of Tc2 cells in the spleen of both Batf3 −/− and B6 mice increased slowly since infection, and then rapidly increased to the top level at 6 weeks post-infection. However, there was no significant difference between these two groups (F (7,15) = 1.540, P = 0.2283) (Fig. 3g, h). Figure 3e and f shows that in the first 3 weeks post-infection, the increase of the percentage of Tc1 cells in the spleen of both Batf3 −/− and B6 mice was accelerated and then decreased from 3 weeks post-infection. Notably, Tc1 cells in Batf3 −/− mice were more than those in B6 control mice at 3, 6 and 9 weeks post-infection (F (7,15) = 30.85, P < 0.0001) (Fig. 3e, f). These results suggest a correlation between the lack of CD8α+ DCs and increased generation of Tc1 cells during S. japonicum infection.
Tc1 cell responses induced by Batf3 independent CD8α+ DCs
The stronger Tc1 cell responses observed in Batf3 −/− mice suggested that the deletion of Batf3 activated CD8+T cells unexpectedly during the natural infection of schistosome. It is of interest how CD8+T cells were activated, since there are no CD8α+ DCs in the spleen of uninfected Batf3 −/− mice (Fig 1c). Surprisingly, there was still a small amount of CD8α+ DCs in the spleen of Batf3 −/− mice at 9 weeks post-infection (Fig. 4a). It was reported that CD8α+DCs differentiation is regulated by a series of transcriptional regulators [16, 24]. We then detected the expression levels of Irf8, PU.1, Id2, Nfil3 and Batf3 in the spleen of Batf3 −/− and B6 mice. Compared to wild-type B6 mice, Irf8 expression in Batf3 −/− mice was higher at 3w, 6w and 9w (F (7,15) = 21.12, P < 0.0001). The expression of PU.1 significantly increased at 3w and 6w (F (7,15) = 7.860, P = 0.0004) (Fig. 4b). However, there were no significant differences in expression levels of Id2 and Nfil3 between Batf3 −/− and B6 mice (F (7,15) = 2.635, P = 0.0514; F (7,15) = 1.970, P = 0.1281, respectively) (Fig. 4b). Our results suggest that in the absence of Batf3, a small amount of Batf3-independent CD8α+ DCs might be compensatorily induced in an Irf8-dependent manner.
Discussion
APC recognizes the endogenous antigen and processes it as antigen peptide-MHCI complex to CD8+T cells to induce CD8+T cell response, while it recognizes the exogenous antigens and processes it as antigen peptide-MHCII complex to CD4+T cells to induce Th cell response [25]. The cross-presentation theory provides a basis for the induction of CD8+T responses during extracellular infection. Dendritic cells are known to be the most powerful APC, and connect innate and adaptive immune responses. The spleen immature DCs of mice can be divided into CD8α+DCs and CD8α−DCs, according to surface molecular markers [26]. Studies have demonstrated that CD8α+DCs play a unique role in cross-presenting [27–29].
In this study, we found that the number of CD8α+DCs in the spleen of mice infected with S. japonicum has the same trend of change with Tc1 response, suggesting that CD8+T cell response in schistosomiasis infection is likely to be related to the cross-presentation of CD8α+ DCs. CD8α+DCs differentiation is regulated by a series of transcriptional regulators, including interferon regulatory factor 8 (Irf8), nuclear factor interleukin 3 (Nfil3), DNA binding inhibitor of DNA binding 2 (Id2) [24, 30–32], and basic leucine zipper transcriptional factor ATF-like 3(Batf3) [16, 24]. Previous studies suggest that the Batf3 plays a key role in the differentiation of CD8α+ DCs, Batf3 −/−mice may lose the ability to cross-present cell-associated antigens and soluble antigens due to the loss of CD8α+ DCs [16, 33, 34]. Hildner et al. [16] reported that Batf3 −/− mice lack virus-specific CD8+T cells when infected with West Nile virus, and Batf3 −/− mice were more likely to develop fibrosarcoma tumor models than wild-type mice because of a lack of CD8+T cell responses. Torti et al. [34] reported a severe deletion of MCMV-specific CD8+T cells in Batf3 −/− mice. Mashayekhi et al. [35] found that Batf3 −/− mice were more likely to be infected by Toxoplasma gondii due to the lack of CD8α+ DCs and decreased IFN-γ and IL-12 production.
To evaluate the role of CD8α+ DCs s in schistosome infection, we infected Batf3 −/− and wild-type B6 mice by S. japonicum cercariae. Our results showed that Batf3 −/− mice had significantly smaller average size of granuloma in the liver, not because of the difference in schistosome egg or worm burden, suggesting that CD8α+ DCs may be involved in the regulation of the granulomatous response during S. japonicum infection. Furthermore, we found that Tc1 cell responses were stronger in S. japonicum infected Batf3 −/− mice. Opposed to previous studies, our findings suggest that during the infection of S. japonicum, the deletion of Batf3 activates CD8+T cells to secrete IFN-γ and attenuate liver pathological damage in mice through immune regulation.
Batf3 −/− mice can compensatorily produce a certain amount of CD8α+ DCs through Irf8 transcription factor pathway, the newly generated CD8α+ DCs express Clec9A on the surface as wild type CD8α+ DCs, and have the same cross-presenting function [36]. Thus, CD8α+ DCs can be divided into Batf3-dependent (Id2-Nfil3-Batf3) and Irf8-dependent (PU.1-Irf8) groups. Ashok et al. [37] reported that Batf3 −/− mice infected with Leishmania major lack CD8α+ DCs cross-presentation, lymphoid cells secreted less IFN-γ and more Th2 and Th17 cytokines, and had severe pathological damage and high worm burden. Sanchez-Paulete et al. [38] reported that because of the lack of cross-presentation activation of tumor antigens and new antigens associated CTLs to participate in immune response, immune regulation monoclonal antibodies lost their enhanced immunotherapeutic effects on tumor therapy in Batf3 −/− mice. These studies suggest that cross-presentation of Batf3-dependent CD8α+ DCs in these models is critical. In 2015, Mott et al. [39] found that a small amount of CD8α + DCs could be detected in Batf3 −/− mice infected with HSV-1, and HSV-1 latency situation in Batf3 −/− mice was not different from wild-type mice, while latent infection was attenuated in BXH 2 mice (Irf8 mutant). This study suggested that cross-presentation of Irf8-dependent CD8α+ DCs may play a critical role in HSV-1 infection. Cross-presentation of Irf8-dependent CD8α+DCs may have a key role in schistosomiasis infection.
Irf8 is one member of the interferon regulatory factors family. Irf8 binds to PU.1 protein and forms a complex to regulate the maturation and function of DCs [40, 41]. In this study we detected a small amount of CD8α+ DCs in Batf3 −/− mice infected with S. japonicum. Compared with wild-type B6 mice, Irf8 and PU.1 were highly expressed in the spleen cells of Batf3 −/− mice. Collectively, our study demonstrated that in the absence of Batf3, a small amount of Batf3-independent CD8α+ DCs might be compensatorily induced in an Irf8-dependent manner. These newly generated CD8α+ DCs may have a more powerful function in cross-presenting and activate CD8+T to secret IFN-γ+ which can attenuate hepatic pathological damage in Batf3 −/− mice.
Conclusions
In summary, by using Batf3 −/− mouse model of schistosomiasis japonica, we demonstrate the association of Batf3 with the immunoregulation of the liver granuloma formation without affecting S. japonicum adult worm load and egg production, suggesting an important role for Batf3 in regulation of Tc1 responses in schistosomiasis. We also demonstrated that without Batf3, mice will compensatorily generate Batf3-independent CD8α+DC. The function of this newly generated CD8α+DC needs to be further investigated. In addition, these novel findings imply that Batf3 may function as a new therapeutic target if it is directly involved in modulating Tc1 cell responses for schistosomiasis and or other immune-associated diseases.
Acknowledgements
Not applicable.
Funding
This work was supported by National Natural Science Foundation of China (NSFC) (Project No. 81201300) to Lin Chen. The funders had no role in study design, data collection and analysis, preparation of the manuscript or decision to publish.
Availability of data and materials
The datasets supporting the conclusions of this article are included within the article.
Authors’ contributions
LC designed and carried out the experiments, analyzed the data and drafted the manuscript. DZ analyzed the data and helped finalize the manuscript. WZ participated in testing the immune responses, MH, JX, BY and YZ participated in the animal experiments. MJ and GW contributed the reagents and materials and helped draft the manuscript. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval
Experiments involving animals were performed in strict accordance with the Regulations for the Administration of Affairs Concerning Experimental Animals (1988.11.1), and all animal procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of Nanjing Medical University for the use of laboratory animals. All the mice were subjected to minimum suffering.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abbreviations
- AOD
IOD/Area
- APC
Antigen-presenting cell
- Batf3
Basic leucine zipper transcriptional factor ATF-like 3
- CD4
Cluster of differentiation 4
- CD8
Cluster of differentiation 8
- CD8+T(CTL)
Cytotoxic T lymphocyte
- FCM
Flow cytometry
- IFN-γ
Interferon gamma
- IL-4
Interleukin 4
- IOD
Integrated optical density
- SEA
Soluble egg antigen
- Th1
Type 1 T helper lymphocytes
- Th2
Type 2 T helper lymphocytes
Contributor Information
Lin Chen, Email: linchen@njmu.edu.cn.
Donghui Zhang, Email: donghuizhang@njmu.edu.cn.
Wenyue Zhang, Email: 269180986@qq.com.
Yuxiao Zhu, Email: 849799734@qq.com.
Min Hou, Email: houmin@njmu.edu.cn.
Bingya Yang, Email: yangbingya2005@163.com.
Zhipeng Xu, Email: zhipengxu@njmu.edu.cn.
Minjun Ji, Email: jiminjun@njmu.edu.cn.
Guanling Wu, Email: glwu@njmu.edu.cn.
References
- 1.Wang Tian-ping CZ-G, Dan-dan L, Xiao-nong Z. Scientific research priority and prospect of schistosomiasis during the 12th five-year lan period in China. Chin J Schisto Control. 2011;23:111–113. [PubMed] [Google Scholar]
- 2.Lewis FA, Tucker MS. Schistosomiasis. Adv Exp Med Biol. 2014;766:47–75. doi: 10.1007/978-1-4939-0915-5_3. [DOI] [PubMed] [Google Scholar]
- 3.Fallon PG, Mangan NE. Suppression of TH2-type allergic reactions by helminth infection. Nat Rev Immunol. 2007;7:220–230. doi: 10.1038/nri2039. [DOI] [PubMed] [Google Scholar]
- 4.Dunne DW, Cooke A. A worm's eye view of the immune system: consequences for evolution of human autoimmune disease. Nat Rev Immunol. 2005;5:420–426. doi: 10.1038/nri1601. [DOI] [PubMed] [Google Scholar]
- 5.Butterworth AE, Vadas MA, Martz E, Sher A. Cytolytic T lymphocytes recognize alloantigens on schistosomula of Schistosoma mansoni, but fail to induce damage. J Immunol. 1979;122:1314–1321. [PubMed] [Google Scholar]
- 6.Chensue SW, Wellhausen SR, Boros DL. Modulation of granulomatous hypersensitivity. II. Participation of Ly1+ and Ly2+ T lymphocytes in the suppression of granuloma formation and lymphokine production in Schistosoma mansoni-infected mice. J Immunol. 1981;127:363–367. [PubMed] [Google Scholar]
- 7.Ragheb S, Boros DL. Characterization of granuloma T lymphocyte function from Schistosoma mansoni-infected mice. J Immunol. 1989;142:3239–3246. [PubMed] [Google Scholar]
- 8.Fidel PL, Jr, Boros DL. Regulation of granulomatous inflammation in murine schistosomiasis. IV. Antigen-induced suppressor T cells down-regulate proliferation and IL-2 production. J Immunol. 1990;145:1257–1264. [PubMed] [Google Scholar]
- 9.Pancre V, Wolowczuk I, Guerret S, Copin MC, Delanoye A, Capron A, et al. Protective effect of rSm28GST-specific T cells in schistosomiasis: role of gamma interferon. Infect Immun. 1994;62:3723–3730. doi: 10.1128/iai.62.9.3723-3730.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Pancre V, Gras-Masse H, Delanoye A, Herno J, Capron A, Auriault C. Induction of cytotoxic T-cell activity by the protective antigen of Schistosoma mansoni Sm28GST or its derived C-terminal lipopeptide. Scand J Immunol. 1996;44:485–492. doi: 10.1046/j.1365-3083.1996.d01-340.x. [DOI] [PubMed] [Google Scholar]
- 11.Zhang M, Gao Y, Du X, Zhang D, Ji M, Wu GL. Toll-like receptor (TLR) 2 and TLR4 deficiencies exert differential in vivo effects against Schistosoma japonicum. Parasite Immunol. 2011;33:199–209. doi: 10.1111/j.1365-3024.2010.01265.x. [DOI] [PubMed] [Google Scholar]
- 12.Tian F, Lin D, Wu J, Gao Y, Zhang D, Ji M, et al. Immune events associated with high level protection against Schistosoma japonicum infection in pigs immunized with UV-attenuated cercariae. PLoS One. 2010;5:e13408. doi: 10.1371/journal.pone.0013408. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Pedras-Vasconcelos JA, Pearce EJ. Type 1 CD8+T cell responses during infection with the helminth Schistosoma mansoni. J Immunol. 1996;157:3046–3053. [PubMed] [Google Scholar]
- 14.Czaja MJ, Weiner FR, Takahashi S, Giambrone MA, van der Meide PH, Schellekens H, et al. Gamma-interferon treatment inhibits collagen deposition in murine schistosomiasis. Hepatology. 1989;10:795–800. doi: 10.1002/hep.1840100508. [DOI] [PubMed] [Google Scholar]
- 15.Fallon PG, Smith P, Dunne DW. Type 1 and type 2 cytokine-producing mouse CD4+ and CD8+ T cells in acute Schistosoma mansoni infection. Eur J Immunol. 1998;28:1408–1416. doi: 10.1002/(SICI)1521-4141(199804)28:04<1408::AID-IMMU1408>3.0.CO;2-H. [DOI] [PubMed] [Google Scholar]
- 16.Hildner K, Edelson BT, Purtha WE, Diamond M, Matsushita H, Kohyama M, et al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science. 2008;322:1097–1100. doi: 10.1126/science.1164206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–8. doi: 10.1006/meth.2001.1262. [DOI] [PubMed] [Google Scholar]
- 18.Ross AG, Bartley PB, Sleigh AC, Olds GR, Li Y, Williams GM, et al. Schistosomiasis. N Engl J Med. 2002;346:1212–1220. doi: 10.1056/NEJMra012396. [DOI] [PubMed] [Google Scholar]
- 19.Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet. 2006;368:1106–1118. doi: 10.1016/S0140-6736(06)69440-3. [DOI] [PubMed] [Google Scholar]
- 20.Ashton PD, Harrop R, Shah B, Wilson RA. The schistosome egg: development and secretions. Parasitology. 2001;122:329–338. doi: 10.1017/S0031182001007351. [DOI] [PubMed] [Google Scholar]
- 21.Hirata M, Kage M, Hara T, Yoneda Y, Zhang M, Fukuma T. Schistosoma japonicum egg granuloma formation in the interleukin-4 or interferon-gamma deficient host. Parasite Immunol. 2001;23:271–280. doi: 10.1046/j.1365-3024.2001.00382.x. [DOI] [PubMed] [Google Scholar]
- 22.Rutitzky LI, Stadecker MJ. Exacerbated egg-induced immunopathology in murine Schistosoma mansoni infection is primarily mediated by IL-17 and restrained by IFN-gamma. Eur J Immunol. 2011;41:2677–2687. doi: 10.1002/eji.201041327. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Kaplan MH, Whitfield JR, Boros DL, Grusby MJ. Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response. J Immunol. 1998;160:1850–1856. [PubMed] [Google Scholar]
- 24.Edelson BT, Kc W, Juang R, Kohyama M, Benoit LA, Klekotka PA, et al. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells. J Exp Med. 2010;207:823–836. doi: 10.1084/jem.20091627. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Bevan MJ. Cross-priming. Nat Immunol. 2006;7:363–365. doi: 10.1038/ni0406-363. [DOI] [PubMed] [Google Scholar]
- 26.Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol. 2002;2:151–161. doi: 10.1038/nri746. [DOI] [PubMed] [Google Scholar]
- 27.Ardavin C. Origin, precursors and differentiation of mouse dendritic cells. Nat Rev Immunol. 2003;3:582–590. doi: 10.1038/nri1127. [DOI] [PubMed] [Google Scholar]
- 28.Pooley JL, Heath WR, Shortman K. Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8− dendritic cells, but cross-presented to CD8+T cells by CD8+ dendritic cells. J Immunol. 2001;166:5327–5330. doi: 10.4049/jimmunol.166.9.5327. [DOI] [PubMed] [Google Scholar]
- 29.Schnorrer P, Behrens GM, Wilson NS, Pooley JL, Smith CM, Sukkari D, et al. The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture. Proc Natl Acad Sci USA. 2006;103:10729–34. [DOI] [PMC free article] [PubMed]
- 30.Belz GT, Nutt SL. Transcriptional programming of the dendritic cell network. Nat Rev Immunol. 2012;12:101–113. doi: 10.1038/nri3149. [DOI] [PubMed] [Google Scholar]
- 31.Kashiwada M, Pham NL, Pewe LL, Harty JT, Rothman PB. NFIL3/E4BP4 is a key transcription factor for CD8alpha(+) dendritic cell development. Blood. 2011;117:6193–6197. doi: 10.1182/blood-2010-07-295873. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Miller JC, Brown BD, Shay T, Gautier EL, Jojic V, Cohain A, et al. Deciphering the transcriptional network of the dendritic cell lineage. Nat Immunol. 2012;13:888–899. doi: 10.1038/ni.2370. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Desch AN, Randolph GJ, Murphy K, Gautier EL, Kedl RM, Lahoud MH, et al. CD103+ pulmonary dendritic cells preferentially acquire and present apoptotic cell-associated antigen. J Exp Med. 2011;208:1789–1797. doi: 10.1084/jem.20110538. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Torti N, Walton SM, Murphy KM, Oxenius A. Batf3 transcription factor-dependent DC subsets in murine CMV infection: differential impact on T-cell priming and memory inflation. Eur J Immunol. 2011;41:2612–2618. doi: 10.1002/eji.201041075. [DOI] [PubMed] [Google Scholar]
- 35.Mashayekhi M, Sandau MM, Dunay IR, Frickel EM, Khan A, Goldszmid RS, et al. CD8alpha(+) dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites. Immunity. 2011;35:249–259. doi: 10.1016/j.immuni.2011.08.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Seillet C, Jackson JT, Markey KA, Brady HJ, Hill GR, Macdonald KP, et al. CD8alpha+ DCs can be induced in the absence of transcription factors Id2, Nfil3, and Batf3. Blood. 2013;121:1574–1583. doi: 10.1182/blood-2012-07-445650. [DOI] [PubMed] [Google Scholar]
- 37.Ashok D, Schuster S, Ronet C, Rosa M, Mack V, Lavanchy C, et al. Cross-presenting dendritic cells are required for control of Leishmania major infection. Eur J Immunol. 2014;44:1422–1432. doi: 10.1002/eji.201344242. [DOI] [PubMed] [Google Scholar]
- 38.Sanchez-Paulete AR, Cueto FJ, Martinez-Lopez M, Labiano S, Morales-Kastresana A, et al. Cancer immunotherapy with immunomodulatory anti-CD137 and anti-PD-1 monoclonal antibodies requires BATF3-dependent dendritic cells. Cancer Discov. 2016;6:71–79. doi: 10.1158/2159-8290.CD-15-0510. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Mott KR, Maazi H, Allen SJ, Zandian M, Matundan H, Ghiasi YN, et al. Batf3 deficiency is not critical for the generation of CD8alpha(+) dendritic cells. Immunobiology. 2015;220:518–524. doi: 10.1016/j.imbio.2014.10.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Tamura T, Yanai H, Savitsky D, Taniguchi T. The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol. 2008;26:535–584. doi: 10.1146/annurev.immunol.26.021607.090400. [DOI] [PubMed] [Google Scholar]
- 41.Carotta S, Willis SN, Hasbold J, Inouye M, Pang SH, Emslie D, et al. The transcription factors IRF8 and PU.1 negatively regulate plasma cell differentiation. J Exp Med. 2014;211:2169–2181. doi: 10.1084/jem.20140425. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The datasets supporting the conclusions of this article are included within the article.